TBX2 and breast carcinoma: Nevertheless binding to the Pten promoter, previously reported in muscle (Zhu et al. 2016), was confirmed, and the reported binding of Tbx2 to the proximal promoter of Ndrg1 in breast cancer cells (Crawford et al. 2019) was also found, although with additional sites occupied within the first intron.